돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 603164생성일: 2026년 10월 27일

3-Chloro-4-(trifluoromethyl)aniline → N-[3-chloro-4-(trifluoromethyl)phenyl]-4-[(1-methylpiperidin-3-yl)methyl]piperazine-1-carboxamide

https://huagongshe.com/reaction/603164

반응식

참여 물질

역할이름HCID투입량
반응물3-Chloro-4-(trifluoromethyl)anilineHCID 67962—
반응물Di-tert-butyl dicarbonateHCID 90495—
반응물1-[(1-Methylpiperidin-3-yl)methyl]piperazineHCID 2736940—
촉매4-(Dimethylamino)pyridineHCID 14284—
용매ChloroformHCID 6212—
생성물N-[3-chloro-4-(trifluoromethyl)phenyl]-4-[(1-methylpiperidin-3-yl)methyl]piperazine-1-carboxamideHCID 115969126.7%

반응 단계

To a solution of di-tert-butyl dicarbonate (114.6 mg) in chloroform (2 ml) was added 4-dimethylaminopyridine (6 mg). A solution of 4-amino-2-chlorobenzotrifluoride (98.1 mg) in chloroform (2 ml) was added and the reaction mixture stirred for 20 minutes at room temperature. A solution of 1-[(1-methylpiperidin-3-yl)methyl]piperazine (98.5 mg) in chloroform (2 ml) was added and the resulting solution was stirred at reflux for 18 hours. The reaction mixture was purified by column chromatography on silica gel (20 g) using a gradient of 100% dichloromethane through to 20% methanolic ammonia in dichloromethane to give the title compound (14 mg).

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US07906645B2
출처 데이터셋uspto-grants-2011_03
ORD IDord-756c6bebf35b4f39a1dcfd943e37587b
출처 메모uspto-grants-2011_03